129 related articles for article (PubMed ID: 1489936)
1. Metabolism of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates undergoing carcinogen bioassay.
Snyderwine EG; Welti DH; Fay LB; Würzner HP; Turesky RJ
Chem Res Toxicol; 1992; 5(6):843-51. PubMed ID: 1489936
[TBL] [Abstract][Full Text] [Related]
2. Metabolic processing and disposition of 2-amino-3-methylimidazo[4,5-f] quinoline (IQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in nonhuman primates.
Snyderwine EG; Turesky RJ; Buonarati MH; Turteltaub KW; Adamson RH
Princess Takamatsu Symp; 1995; 23():69-77. PubMed ID: 8844797
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of the food-derived carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in nonhuman primates.
Snyderwine EG; Welti DH; Davis CD; Fay LB; Turesky RJ
Carcinogenesis; 1995 Jun; 16(6):1377-84. PubMed ID: 7788858
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin-H synthase mediated metabolism and mutagenic activation of 2-amino-3-methylimidazo [4,5-f] quinoline (IQ).
Wolz E; Wild D; Degen GH
Arch Toxicol; 1995; 69(3):171-9. PubMed ID: 7717873
[TBL] [Abstract][Full Text] [Related]
5. DNA adduct formation of the food-derived mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates undergoing carcinogen bioassay.
Turesky RJ; Gremaud E; Markovic J; Snyderwine EG
Chem Res Toxicol; 1996 Mar; 9(2):403-8. PubMed ID: 8839042
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of heterocyclic aromatic amines and strategies of human biomonitoring.
Turesky RJ; Fay LB; Welti DH
Princess Takamatsu Symp; 1995; 23():59-68. PubMed ID: 8844796
[TBL] [Abstract][Full Text] [Related]
7. Induction of hepatocellular carcinoma in nonhuman primates by the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline.
Adamson RH; Takayama S; Sugimura T; Thorgeirsson UP
Environ Health Perspect; 1994 Feb; 102(2):190-3. PubMed ID: 8033850
[TBL] [Abstract][Full Text] [Related]
8. Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
Sadrieh N; Snyderwine EG
Carcinogenesis; 1995 Jul; 16(7):1549-55. PubMed ID: 7614688
[TBL] [Abstract][Full Text] [Related]
9. The effect of dose and cytochrome P450 induction on the metabolism and disposition of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx) in the rat.
Turesky RJ; Markovic J; Bracco-Hammer I; Fay LB
Carcinogenesis; 1991 Oct; 12(10):1847-55. PubMed ID: 1934266
[TBL] [Abstract][Full Text] [Related]
10. Identification of new 2-amino-3-methylimidazo[4,5-f]quinoline urinary metabolites from beta-naphthoflavone-treated mice.
Lakshmi VM; Hsu FF; Zenser TV
Drug Metab Dispos; 2009 Aug; 37(8):1690-7. PubMed ID: 19451400
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in human hepatocytes: 2-amino-3-methylimidazo[4,5-f]quinoxaline-8-carboxylic acid is a major detoxification pathway catalyzed by cytochrome P450 1A2.
Langouët S; Welti DH; Kerriguy N; Fay LB; Huynh-Ba T; Markovic J; Guengerich FP; Guillouzo A; Turesky RJ
Chem Res Toxicol; 2001 Feb; 14(2):211-21. PubMed ID: 11258970
[TBL] [Abstract][Full Text] [Related]
12. Fate of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in Sprague-Dawley rats. I. Mutagens in the urine.
Barnes WS; Weisburger JH
Mutat Res; 1985; 156(1-2):83-91. PubMed ID: 3889629
[TBL] [Abstract][Full Text] [Related]
13. Metabolic processing and carcinogenicity of heterocyclic amines in nonhuman primates.
Adamson RH; Snyderwine EG; Thorgeirsson UP; Schut HA; Turesky RJ; Thorgeirsson SS; Takayama S; Sugimura T
Princess Takamatsu Symp; 1990; 21():289-301. PubMed ID: 2134682
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin H synthase-dependent formation of the direct-acting mutagen 2-nitro-3-methylimidazo[4,5-f]quinoline (nitro-IQ) from IQ.
Morrison LD; Eling TE; Josephy PD
Mutat Res; 1993 May; 302(1):45-52. PubMed ID: 7683106
[TBL] [Abstract][Full Text] [Related]
15. Species differences in metabolism of heterocyclic aromatic amines, human exposure, and biomonitoring.
Turesky RJ; Gross GA; Stillwell WG; Skipper PL; Tannenbaum SR
Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):47-51. PubMed ID: 7889858
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of the food-borne carcinogens 2-amino-3-methylimidazo-[4,5-f]quinoline and 2-amino-3,8- dimethylimidazo[4,5-f]-quinoxaline in the rat as a model for human biomonitoring.
Turesky RJ; Stillwell WG; Skipper PL; Tannenbaum SR
Environ Health Perspect; 1993 Mar; 99():123-8. PubMed ID: 8319609
[TBL] [Abstract][Full Text] [Related]
17. Genotoxicity of the food mutagen 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ) and analogs.
Barnes WS; Lovelette CA; Tong C; Williams GM; Weisburger JH
Carcinogenesis; 1985 Mar; 6(3):441-4. PubMed ID: 3884172
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of 2-amino-3-methylimidazo[4,5-f]quinoline in the male rat.
Inamasu T; Luks H; Vavrek MT; Weisburger JH
Food Chem Toxicol; 1989 Jun; 27(6):369-76. PubMed ID: 2792966
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of metabolites of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline formed after incubation with isolated rat liver cells.
Alexander J; Holme JA; Wallin H; Becher G
Chem Biol Interact; 1989; 72(1-2):125-42. PubMed ID: 2510946
[TBL] [Abstract][Full Text] [Related]
20. Genotoxic activity of the N-acetylated metabolites of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ).
Brunborg G; Holme JA; Alexander J; Becher G; Hongslo JK
Mutagenesis; 1988 Jul; 3(4):303-9. PubMed ID: 3062317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
